Company: HSDTW
Filing Date: 2025-05-02
Form Type: DEF 14A
Source: 0001104659-25-044128
Chunk: 27

Company: Solana Co
Filing Date: 2025-05-02
Form: DEF 14A
Chunk 27
---
 HELIUS MEDICAL

#### TECHNOLOGIES, INC. 2022 EQUITY INCENTIVE PLAN
Background and Purpose of the 2022 Equity Incentive Plan Amendment

Our stockholders are being asked to approve the Second Amendment to the Helius Medical Technologies, Inc. 2022 Equity Incentive Plan (the “

#### Amendment
”). On April 22, 2025, our Board, upon the recommendation of our Compensation Committee, approved the Amendment, subject to stockholder approval at the Special Meeting. The Helius Medical Technologies, Inc. 2022 Equity Incentive Plan (the “

#### 2022 Equity Incentive Plan
”) was initially adopted by our Board on February 16, 2022 and by our stockholders on May 23, 2022.

We use awards under the 2022 Equity Incentive Plan to attract and retain employees, ensure that our compensation program provides appropriate incentives to motivate our key employees, consultants, officers and non-employee directors to contribute to our long-term performance and growth, develop a culture of ownership and further align the interests of the participants and our stockholders. The life sciences market is highly competitive, and our results are largely attributable to the talents, expertise, efforts and dedication of our employees, consultants, officers and non-employee directors. Our compensation program, including the granting of equity compensation, is a crucial way to attract and recruit new employees and consultants and retain existing employees and consultants, with equity compensation serving as our primary recruitment, retention and motivational tool as opposed to cash compensation. Stockholder approval of the Amendment will permit us to continue to grant equity compensation awards to our key employees, consultants, officers and non-employee directors in furtherance of this philosophy.

While we do have an evergreen provision in our 2022 Equity Incentive Plan that allows for automatic replenishment of the equity share pool on an annual basis, we believe that if we undertake the financing set forth in Proposal 3, we will not have enough shares to assist with recruitment and retention of the necessary talent even with the evergreen provision, and, if the Amendment is not approved, we will be significantly limited in our ability to offer equity awards as a component of compensation.

Our Board has determined that it is in the best interests of us and our stockholders to approve the Amendment. Pursuant to the terms and conditions of the Amendment, the 2022 Equity Incentive Plan would be amended to provide for a one-time interim evergreen provision